| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 673016 | 62263 | NATECAL D 1.500 MG/400 UI COMPRIMIDOS MASTICABLES | NATECAL D 1.500 MG/400 UI COMPRIMIDOS MASTICABLES , 60 comprimidos | 1.500 mg (600 mg Ca)/400 UI | 72 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62263/62263_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62263/62263_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | ITALFARMACO S.A. | 1999-02-01 | 1 | 1 | 1 | 1999-02-01 | 2011-05-30 | 1 | 2011-07-11 | 656405 | View Edit Delete | |||||||||||
| 672129 | 63677 | EPINITRIL 10 mg/24 H PARCHES TRANSDERMICOS | EPINITRIL 10 mg/24 H PARCHES TRANSDERMICOS, 30 parches | 10 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63677/63677_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63677/63677_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2001-02-20 | 1 | 1 | 1 | 2001-02-20 | 2011-03-07 | 0 | 2011-04-12 | 705103 | View Edit Delete | |||||||||||
| 672130 | 63678 | EPINITRIL 15 mg/24 H PARCHES TRANSDERMICOS | EPINITRIL 15 mg/24 H PARCHES TRANSDERMICOS, 30 parches | 15 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63678/63678_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63678/63678_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2001-02-20 | 1 | 1 | 1 | 2001-02-20 | 2011-03-07 | 0 | 2011-04-12 | 705681 | View Edit Delete | |||||||||||
| 672131 | 63676 | EPINITRIL 5mg / 24H PARCHES TRANSDERMICOS | EPINITRIL 5mg / 24H PARCHES TRANSDERMICOS, 30 parches | 5 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63676/63676_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63676/63676_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2001-02-20 | 1 | 1 | 1 | 2001-02-20 | 2011-03-07 | 0 | 2011-04-12 | 704668 | View Edit Delete | |||||||||||
| 672498 | 73003 | CLOPERASTINA NORMON 3,54 mg/ml SUSPENSION ORAL | CLOPERASTINA NORMON 3,54 mg/ml SUSPENSION ORAL, 1 frasco de 120 ml | 3,54 mg/ml | 88 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73003/73003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73003/73003_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-11-15 | 1 | 1 | 1 | 2010-11-15 | 2010-11-15 | 1 | 2011-06-28 | View Edit Delete | ||||||||||||
| 672499 | 73003 | CLOPERASTINA NORMON 3,54 mg/ml SUSPENSION ORAL | CLOPERASTINA NORMON 3,54 mg/ml SUSPENSION ORAL, 1 frasco de 200 ml | 3,54 mg/ml | 88 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73003/73003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73003/73003_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-11-15 | 1 | 1 | 1 | 2010-11-15 | 2010-11-15 | 1 | 2011-05-18 | View Edit Delete | ||||||||||||
| 672313 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 10 l | 99,5 % v/v | 95 | 10 | 25 | 1 recipiente criogénico móvil de 10 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672314 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 20 l | 99,5 % v/v | 95 | 20 | 25 | 1 recipiente criogénico móvil de 20 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672315 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 21 l | 99,5 % v/v | 95 | 21 | 25 | 1 recipiente criogénico móvil de 21 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672316 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 30 l | 99,5 % v/v | 95 | 30 | 25 | 1 recipiente criogénico móvil de 30 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672317 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 31 l | 99,5 % v/v | 95 | 31 | 25 | 1 recipiente criogénico móvil de 31 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672318 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 36 l | 99,5 % v/v | 95 | 36 | 25 | 1 recipiente criogénico móvil de 36 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672319 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 37 l | 99,5 % v/v | 95 | 37 | 25 | 1 recipiente criogénico móvil de 37 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672320 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 41 l | 99,5 % v/v | 95 | 41 | 25 | 1 recipiente criogénico móvil de 41 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672321 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 45 l | 99,5 % v/v | 95 | 45 | 25 | 1 recipiente criogénico móvil de 45 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672322 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 46 l | 99,5 % v/v | 95 | 46 | 25 | 1 recipiente criogénico móvil de 46 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672323 | 72583 | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L. | OXIGENO MEDICINAL LIQUIDO OXIPHARMA, S. L., 1 recipiente criogénico móvil de 60 l | 99,5 % v/v | 95 | 60 | 25 | 1 recipiente criogénico móvil de 60 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72583/72583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72583/72583_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11046 | OXIPHARMA S.L. | 2010-07-27 | 1 | 1 | 1 | 2010-07-27 | 2010-07-27 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 676509 | 73054 | ROPIVACAINA KABI 2MG/ML SOLUCION INYECTABLE EFG | ROPIVACAINA KABI 2MG/ML SOLUCION INYECTABLE EFG , 5 ampollas de 10 ml | 2 mg/ml inyectable 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73054/73054_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73054/73054_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-13 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 676514 | 73056 | ROPIVACAINA KABI 7,5 MG/ML SOLUCION INYECTABLE EFG | ROPIVACAINA KABI 7,5 MG/ML SOLUCION INYECTABLE EFG , 5 ampollas de 10 ml | 7,5 mg/ml inyectable de 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73056/73056_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73056/73056_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-13 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 676516 | 73057 | ROPIVACAINA KABI 10 MG/ML SOLUCION INYECTABLE EFG | ROPIVACAINA KABI 10 MG/ML SOLUCION INYECTABLE EFG , 5 ampollas de 10 ml | 10 mg/ml inyectable 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73057/73057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73057/73057_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-13 | 1 | 2015-05-26 | View Edit Delete |
Page 269 of 1035, showing 20 records out of 20697 total, starting on record 5361, ending on 5380